Full Text View
Tabular View
No Study Results Posted
Related Studies
CJD (Creutzfeldt-Jakob Disease) Quinacrine Study
This study is ongoing, but not recruiting participants.
Study NCT00183092   Information provided by National Institute on Aging (NIA)
First Received: September 14, 2005   Last Updated: March 10, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Creutzfeldt-Jakob Disease
Additional conditions recognized in this trial
Creutzfeldt-Jakob Syndrome
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Central Nervous System Infections
Delirium, Dementia, Amnestic, Cognitive Disorders
Dementia
Mental Disorders
Nervous System Diseases
Prion Diseases
Interventions listed in this trial
Quinacrine
More general drug interventions related to this trial
Anthelmintics
Anti-Infective Agents
Anticestodal Agents
Antimalarials
Antinematodal Agents
Antineoplastic Agents
Antiparasitic Agents
Antiplatyhelmintic Agents
Antiprotozoal Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Institute on Aging (NIA)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services